Shares of EnteroMedics Inc (NASDAQ:ETRM) ended Thursday session in green amid volatile trading. The shares closed up +0.003 points or 2.38% at $0.138 with 6.02 million shares getting traded. Post opening the session at $0.14, the shares hit an intraday low of $0.13 and an intraday high of $0.14 and the price vacillated in this range throughout the day. The company has a market cap of $9.31 million and the numbers of outstanding shares have been calculated to be 69.70 million shares.
EnteroMedics Inc (ETRM) on Sept. 13, 2016 announced clinical success at the Bariatric Center at Sky Ridge Medical Center in Colorado, a vBloc Institute partner, where several vBloc procedures have been performed to date by Frank H. Chae, MD, FACS, Chief Surgeon and Head of the Bariatric Center at Sky Ridge Medical Center. vBloc Institute partners are facilities that have integrated vBloc Therapy and vBloc Achieve into their practices.
“The weight loss observed in my vBloc patients is trending greater than reported in the vBloc ReCharge Study,” said Dr. Chae. “Our patients have experienced more than 30 percent improvement in the percent total weight loss (TWL) in the first three months when compared to the ReCharge Study patients. While our observations are not a clinical trial, the positive results of these practical applications should be recognized, particularly as vBloc moves towards obtaining broad reimbursement coverage.”
vBloc Therapy is approved for use in helping with weight loss in people aged 18 years and older who are obese, with a BMI of 40 to 45 kg/m, or a BMI of 35 to 39.9 kg/m with a related health condition such as Type 2 diabetes, high blood pressure, high cholesterol levels or obstructive sleep apnea.
“vBloc Therapy is a revolutionary treatment option for morbidly obese patients who do not wish to undergo anatomy-altering weight-loss procedures,” continued Dr. Chae. “I would expect vBloc to be the preferred choice of eligible patients when there is insurance coverage and they do not have to carry the full financial burden themselves.”
Shares of Abbott Laboratories (NYSE:ABT) ended Thursday session in green amid volatile trading. The shares closed up +0.30 points or 0.72% at $42.22 with 5.83 million shares getting traded. Post opening the session at $42.16, the shares hit an intraday low of $42.03 and an intraday high of $42.49 and the price vacillated in this range throughout the day. The company has a market cap of $62.57 billion and the numbers of outstanding shares have been calculated to be 1.47 billion shares.
Abbott Laboratories (ABT) will announce its third-quarter 2016 financial results on Wednesday, Oct. 19, 2016, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern), and will be accessible through Abbott’s Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available after 11 a.m. Central time.